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The NADPH oxidase in neutrophils was specifically solubilized from membrane vesicles of porcine blood 
neutrophils and rapidly concentrated byimmunoprecipitation with cross-reacting anti-P-450 reductase IgG. 
The precipitates from both myristic acid-stimulated and resting cells contained one third of the cytochrome 
b-558 and were slightly contaminated with myeloperoxidase. The immunoprecipitate from stimulated cells 
gave rhombic high-spin ESR signals of a heme at g = 6.47 and 5.49, which were insensitive to KCN, whereas 
the preparation from resting cells did not give these signals. The rhombic high-spin signals are discussed 
in view of the participation of cytochrome b-558 in the NADPH oxidase system. 
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1. INTRODUCTION 
When exposed to bacteria and certain stimuli, 
neutrophils exhibit a KCN-insensitive respiratory 
burst that results in production .of superoxide 
anion (02- [1-4]. An NADPH oxidase found in 
neutrophil plasma membrane is the key enzyme in 
this respiratory burst, since stimulation of the cells 
induces rapid turnover of the oxidase [2,3]. This 
enzyme activity is not present in neutrophils of pa- 
tients with chronic granulomatous disease (CGD) 
[5], indicating the importance of the oxidase 
system for bactericidal activity. 
Several methods have been used in attempts to 
isolate the oxidase, but still little is known about its 
structure and reaction mechanism. Its active 
centers have been suggested to be flavin and b-type 
cytochrome (cytochrome b-558) from the follow- 
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ing findings. (i) The enzymatic activity is inhibited 
by an FAD analogue, 5-carba-5-deaza-FAD [6]. 
(ii) A flavoprotein with an oxidation-reduction 
midpoint potential of -280  mV at pH 7.0 that 
probably reacts with NADPH in the stimulated 
state of the oxidase has been found in the 
neutrophil membrane fraction [7]. (iii) An 
O~--forming enzyme isolated by dye-affinity 
chromatography was shown to contain FAD [8]. 
(iv) An NADPH oxidoreductase containing an 
FAD protein, which was recently separated in our 
laboratory by isoelectric focussing on gel, seems to 
be responsible for the respiratory burst of the ox- 
idase and has the ability to transfer electrons to a 
heme-protein (Kakinuma, K. et al., submitted). (v) 
There is no b-type cytochrome in neutrophils from 
the X-linked form of CGD [9,10]. (vi) Cytochrome 
b-558 was found to have a low midpoint potential 
of -245  mV [11]. (vii) Pyridine and imidazole, 
which bind to cytochrome b-558, inhibit the ox- 
idase activity [12]. 
This paper reports a new method for the concen- 
tration of NADPH oxidase in an active form and 
studies on its ESR spectrum. The NADPH oxidase 
in neutrophil membranes was solubilized with 
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detergents, and promptly concentrated by im- 
munoprecipitation. Immunoprecipitation was 
achieved with anti-P-450 reductase IgG, which has 
been reported to cross-react weakly with the ox- 
idase [13]. The precipitate obtained from 
stimulated neutrophils showed remarkable 
superoxide-generating activity, unlike that obtain- 
ed from resting cells. The difference found in the 
ESR signals of the samples from stimulated and 
resting cells is discussed in relation to the NADPH 
oxidase system. 
jected into a male rabbit. Further injections of 
1.4 ml of the same antigen fraction were given 5 
times at 10-day intervals before preparation of im- 
mune serum. The IgG fractions from preimmune 
and immune sera were prepared by column 
chromatography on protein A-Sepharose CL-4B 
(Pharmacia). The antigen specificity of the IgG 
fractions was examined by the method of 
Ouchterlony and Nilsson [17]. The IgG fraction of 
immune serum formed a single precipitin line vs 
the purified P-450 reductase. 
2. MATERIALS AND METHODS 
2.1. Purification of porcine P-450 reductase 
P-450 reductase activity was assayed by the 
method of Omura and Takesue [14]. A porcine 
liver microsome fraction was prepared and 
digested with trypsin by the methods of Iyanagi et 
al. [15,16]. The supernatant of the trypsin digest 
was applied to a DEAE-Sephacel column (Phar- 
macia) (3 x 10 cm) previously equilibrated with 
0.1 M potassium phosphate buffer (pH 7.7) con- 
taining 1 mM EDTA, washed with the same buf- 
fer, and developed with a linear gradient (600 ml) 
of 0-0.5 M KC1 in 1 mM EDTA/0.1 M potassium 
phosphate buffer (pH 7.7). Fractions of eluate 
with high reductase activity were combined and ap- 
plied to a 2 ' ,5 ' -ADP-Sepharose column (Phar- 
macia) (0.8 x 12 cm) equilibrated with 0.1 mM 
EDTA/0.1 M potassium phosphate buffer. The 
column was washed with 0.3 M potassium 
phosphate buffer (pH 7.7) containing 0.1 mM 
EDTA, and then with the same buffer containing 
0.2 mM NADP ÷. Material was eluted with the 
buffer solution containing 10 mM NADP +. The 
purified P-450 reductase obtained in this way ap- 
peared free from other proteins by analytical gel 
electrophoresis. 
2.2. Preparation of anti-porcine liver P-450 
reductase IgG 
The purified P-450 reductase was dialyzed vs 
0.9% NaC1 in 10 mM potassium phosphate buffer 
(pH 7.5) for 4 h and concentrated by ultrafiltra- 
tion (Amicon, PM-30 membrane) to a concentra- 
tion of 2 mg protein/ml. Then 1 ml of the 
concentrated enzyme was emulsified with an equal 
volume of Freund's complete adjuvant (Iatron), 
and the emulsion (2.0 ml) was hypodermically in- 
2.3. Preparation of neutrophils and membrane 
vesicles 
Porcine blood neutrophils were separated by the 
method of Wakeyama et al. [18]. The cells were 
briefly incubated at 37°C with and without 
myristic acid [3] and centrifuged at 1000 x g for 
5 min, the cell pellets being stored at -80°C for 
use in preparation of membrane vesicles [19]. The 
cells were thawed, disrupted by sonication, mixed 
with phenylmethylsulfonyl fluoride (PMSF) at a 
final concentration of 1 mM, and centrifuged at 
1000 x g for 20 rain. The resulting supernatant was 
recentrifuged at 100000 x g for 60 min to obtain 
membrane vesicles. 
2.4. Solubilization of the NADPH oxidase 
NADPH oxidase was solubilized at 0-4°C. The  
membrane vesicles were suspended at a final con- 
centration of 8 mg protein/ml in a solution of 
0.2°7o (w/v) potassium deoxycholate, 0.25 M 
sucrose and 10 mM Hepes/NaOH buffer (pH 7.4). 
The mixture was stirred for 30 min, then centri- 
fuged at 100000 x g for 45 min, and the pecipitate 
was suspended in a mixture of 37.5°7o (v/v) 
glycerol, 0.156 M sucrose and 6.25 mM 
Hepes/NaOH buffer (pH 7.4) with 80°7o by 
volume of the original deoxycholate mixture by 
homogenization i  a glass homogenizer. Then 5 °70 
n-octyl-~'-D-glucoside (Dotito) was added to the 
mixture to give a final concentration of 1% with 
stirring. The mixture was stirred for 30 min, cen- 
trifuged at 100000 x g for 60 min, and the super- 
natant fraction used for immunoprecipitation. 
2.5. Immunoprecipitation of the NADPH oxidase 
Immunoprecipitation was performed at 0-4°C. 
The solubilized fraction was diluted with an equal 
volume of a mixture of 0.1 °70 octylglucoside, 30°7o 
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(v/v) glycerol and 10 mM Hepes/NaOH buffer 
(pH 7.4) (OGH buffer). After addition of the anti- 
P-450 reductase IgG fraction (final 0.1 mg pro- 
tein/ml), the protease inhibitors 2 mM PMSF, 
2 mM N-p-tosyl-L-lysine chloromethyl ketone, 
and 0.4-0.9 mM leupeptin were promptly added. 
The suspension was incubated at 2°C for 12 h, and 
then mixed with an anti-rabbit goat IgG fraction 
(Cappel; y-chain-specific; final 0.2 mg pro- 
tein/ml), and allowed to stand for 3 h at 2°C. The 
immunoprecipitate was collected by centrifugation 
at 50000 × g for 30 min, suspended in a small 
volume of OGH buffer and stored at -80°C.  
2.6. Determination of NADPH oxidase activity 
The O~--generating activity of the oxidase was 
assayed by measuring superoxide dismutase 
(37.5/~g protein/ml) inhibitable reduction of 
cytochrome c [20] in a Hitachi 556 dual- 
wavelength spectrophotometer. The assay mixture 
contained an aliquot of sample, 50/zM cytochrome 
c, catalase at 6/zg protein/ml, and 0.17 M sucrose 
in 65 mM sodium-potassium phosphate buffer 
(pH 7.0). The reaction was started by addition of 
0.1 mM NADPH.  
2.7. Spectrophotometric determinations of 
cytochrome b-558 and myeloperoxidase 
Absorption spectra were recorded with a Hitachi 
557 dual-wavelength spectrophotometer at 20°C. 
The contents of cytochrome b-558 and 
myeloperoxidase were determined from the dif- 
ference spectra of sodium dithionite reduced minus 
oxidized samples using molar extinction coeffi- 
cients of 21.6 × 10 3 (559-540 nm) [21] and 75.0 × 
103 (472 nm) [22] cm -x -M -1, respectively. 
2.8. ESR measurement 
ESR spectra were recorded in an X-band JES- 
FE 2XG spectrometer (JEOL), equipped with a 
sample dewar containing liquid helium. The condi- 
tions for measurements were as follows: 
microwave power, 5 mW; modulation amplitude, 
20 G at 100 kHz; magnetic field, 1500 ___ 1000 G; 
response, 1 s; sweep time, 4 min; amplitude, 
× 2500; temperature, 4.2 K. 
2.9. Other methods 
Myeloperoxidase of porcine neutrophils was 
purified by the method of Odajima [23]. The 
Aa30nm/Z28onrn ratio of the enzyme preparation 
used in this work was 0.5. Protein was determined 
by the method of Lowry et al. [24] with bovine 
serum albumin as a standard. Analytical polyacryl- 
amide gel electrophoresis in the presence of SDS 
was carried out using the system reported by 
Laemmli [25]. 
3. RESULTS AND DISCUSSION 
Results on solubilization and immunoprecipita- 
tion of NADPH oxidase of neutrophils are sum- 
marized in table 1. Membrane vesicles were 
pretreated with a low concentration of deoxy- 
Table 1 
Heme contents and NADPH oxidase activity 
Protein Cyt.b-558 MPO NADPH oxidase Spec. 
(mg) (nmol) (nmol) activity a act. b 
Membrane S 80.0 22.9 14.3 8650 378 
vesicles R 80.0 19.2 9.7 0 0 
Solubilized S 3.5 12.8 0.58 3270 255 
supernatant R 3.9 10.6 0.46 0 0 
Immuno- S n.d. 6.9 0.36 1280 186 
precipitate R n.d. 7.8 0.45 0 0 
a nmol O~/min 
b nmol O~/min per nmol cyt. b-558 
Assays are described in section 2. Cyt., cytochrome; MPO, myeloperoxidase; S, preparation 
from stimulated neutrophils; R, preparation from resting neutrophils, n.d., not determined 
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cholate to remove peripheral membrane proteins, 
and then the membrane-bound NADPH oxidase 
was specifically solubilized with 1°70 oc- 
tylglucoside. The solubilized supernatant contain- 
ed 3807o f the NADPH oxidase activity and 5607o 
of the cytochrome b-558. Its contamination with 
myeloperoxidase, another heine-protein in 
neutrophils, was low (4070). The solubilized 
NADPH oxidase was precipitated by its cross- 
reaction with anti-P-450 reductase IgG. Anti- 
P-450 reductase IgG was used at a concentration of
0.1 mg protein/ml for immunoprecipitation, and 
had no inhibitory effect on the NADPH oxidase 
activity at up to 0.3 mg protein/ml. The 
coprecipitate contained 3907o of the NADPH ox- 
idase activity and 60070 of the cytochrome b-558 of 
the solubilized supernatant fraction. The yields of 
cytochrome b-558 and myeloperoxidase from 
stimulated and resting cells were similar (table 1). 
This immunoprecipitation is useful for obtain- 
ing concentrated NADPH oxidase in an active 
form. Furthermore, with membrane vesicles [7] 
and Percoll-isolated membrane vesicles [26], we 
have been unable to measure ESR spectra due to 
interference by contaminating materials (not 
shown), but these immunoprecipitation contained 
very small amounts of non-heine iron giving an 
ESR signal of about g = 4.3 [23] and of 
myeloperoxidase, and so weak ESR signals could 
be detected at low magnetic field without signifi- 
cant interference. 
Fig. la,b shows the ESR spectra of the im- 
munoprecipitates prepared from stimulated and 
resting neutrophils, respectively. In both prepara- 
tions, signals of hemes were detected only at low 
magnetic field. Fig.lc shows the ESR signals of 
myeloperoxidase purified from porcine neu- 
trophils. The result shows that the signals of 
the immunoprecipitation at g = 6.78 and 5.12 
(fig.la,b) were due to the myeloperoxidase. The 
axial signal at g = 6.00 obtained with both prepara- 
tions (fig.la,b) might be attributable to 
cytochrome b-558 or contaminating hemoglobin 
derivatives. In contrast, only the preparation from 
stimulated cells gave signals at g = 6.47 and 5.49 
(fig.la). These signals seem to be attributable to 
the cytochrome b-558 associating with the 
NADPH oxidase in the stimulated state, since the 
electronic state of the other hemes contaminating 
the preparation would not be changed by genera- 
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Fig.1. ESR signals from neutrophils. Conditions for 
ESR measurements were: microwave power, 5 mW; 
modulation amplitude, 20 G at 100 kHz; temperature, 
4.2 K; magnetic field, 1500 + 1000 G. (a) 
lmmunoprecipitate from stimulated cells (2.0/zM 
cytochrome b-558); (b) immunoprecipitate from resting 
cells (2.7 aM cytochrome b-558); (c) purified 
myeloperoxidase (0.45/~M heme). 
tion of superoxide anion, except those of ESR- 
silent oxygen intermediates of myeloperoxidase. 
Next, we reduced both preparations with sodium 
dithionite and measured their ESR signals (not 
shown). No distinguishable signal was obtained, 
suggesting the absence of an iron-sulfur complex in 
the oxidase. 
For further assignment, we examined the effect 
of 10raM KCN on these high-spin signals 
(fig.2a,b). We found that KCN diminished the 
high-spin ESR signals at g -- 6.78 and 5.12. This 
finding confirmed that these signals were due to 
myeloperoxidase, because the CN-ligated form of 
myeloperoxidase has been reported to lose its high- 
spin ESR signals [23]. The axial high-spin signal at 
282 
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Fig.2. Effects of KCN on ESR signals from neutrophils. 
l0 mM KCN was added to each preparation and the 
mixtures incubated for 5 min at 20°C. Conditions for 
ESR measurements and cytochrome contents of each 
sample were as for fig.1. (a) Immunoprecipitate from 
stimulated cells; (b) immunoprecipitate from resting 
ceils. 
g = 6.00 was decreased by the addition of KCN, 
while the signals at g = 6.47 and 5.54 were KCN- 
insensitive. Although high-spin hemes-are em- 
pirically thought o be KCN-sensitive, some mem- 
brane intrinsic heine-proteins are KCN-insensitive, 
such as the b-type cytochrome of the bd-type ox- 
idase complex in Escherichia coli [27]. Therefore, 
the rhombic signals might be attributable to the 
cytochrome b-558 associated with KCN-insensitive 
NADPH oxidase in the neutrophil membrane frac- 
tion, and the oxidized cytochrome b-558 in the 
stimulated state is suggested to be in a high-spin 
state as for other terminal oxidases [28,29]. 
Recently, two groups have reported evidence for 
a molecular change in cytochrome b-558 following 
cell stimulation: Papini et al. [30] reported that a 
31.5 kDa protein, probably cytchrome b-558, was 
phosphorylated after stimulation of the NADPH 
oxidase. Iizuka et al. [31] demonstrated using low- 
temperature absorption spectrophotometry that 
the main peak of the oe-band of the cytochrome 
b-558 split into double peaks when the cells were 
stimulated anaerobically. In view of these findings, 
we propose that a change in the electronic state of 
cytochrome b-558 occurs following stimulation of 
the NADPH oxidase system. 
ACKNOWLEDGEMENTS 
We are grateful to Dr T. Iyanagi (Tsukuba 
University) for helpful advice on purification of 
porcine P-450 reductase. We are also grateful to 
Drs T. Ohnishi (University of Pennsylvania), S. 
Itoh (National Institutes for Basic Biology, 
Okazaki) and K. Kita (Juntendo University) for 
helpful discussions. We thank Mrs Y. Fukuhara, 
Mr K. Sato and Mr T. Yamaguchi (Tokyo 
Metropolitan Institute of Medical Science) for sug- 
gestions and technical advice. 
REFERENCES 
[1] Sbarra, A.J. and Karnovsky, M.L. (1959) J. Biol. 
Chem. 234, 1355-1362. 
[2] Zatti, M. and Rossi, F. (1966) Experientia 22, 
758-759. 
[3] Kakinuma, K. (1974) Biochim. Biophys. Acta 348, 
76-85. 
[4] Babior, B.M. (1978) N. Engl. J. Med. 298, 
659-668. 
[5] Holmes, B., Page, A.R. and Good, R.A. (1967) J. 
Clin. Invest. 46, 1422-1432. 
[6] Light, D.R., Walsh, C., O'Callaghan, A.M., 
Goetzl, E.J. and Tauber, A.J. (1981) Biochemistry 
20, 1468-1476. 
[7] Kakinuma, K., Kaneda, M., Chiba, T. and 
Ohnishi, T. (1986) J. Biol. Chem. 261, 9426-9432. 
[8] Glass, G.A., Delisle, D.M., DeTogni, P., Gabig, 
T.G., Magee, B.H., Markert, M. and Babior, B.M. 
(1986) J. Biol. Chem. 261, 13247-13251. 
[9] Segal, A.W., Jones, O.T.G., Webster, D. and 
Allison, A.C. (1978) Lancet 2, 446-449. 
[10] Segal, A.W., Cross, A.R., Garcia, R.C., 
Borregaard, N., Valerius, N.H., Soothill, J.F. and 
Jones, O.T.G. (1983) N. Engl. J. Med. 308, 
245-251. 
[11] Cross, A.R., Jones, O.T.G., Harper, A.M. and 
Segal, A.W. (1981) Biochem. J. 194, 599-606. 
[11] Iizuka, T., Kanegasaki, S., Makino, R., Tanaka, 
T. and Ishimura, Y. (1985) Biochem. Biophys. Res. 
Commun. 130, 621-626. 
[13] Takayama, H., Iwaki, S., Tamoto, K. and 
Koyama, J. (1984) Biochim. Biophys. Acta 799, 
151-157. 
[14] Omura, T. and Takesue, S. (1970) J. Biochem. 
(Tokyo) 67, 249-257. 
283 
Volume 214, number 2 FEBS LETTERS April 1987 
[15] Iyanagi, T. and Mason, H.S. (1973) Biochemistry 
12, 2297-2308. 
[16] Haniu, M., lyanagi, T., Legesse, K. and Shively, 
.I.E. (1984) ,i. Biol. Chem. 259, 13703-13711. 
[17] Ouchterlony, O. and Nilsson, L.-A. (1978) in: 
Handbook of Experimental Immunology, vol.1, 
3rd edn (Weir~ D.M. ed.) pp.19.1-19.44, 
Blackwell, Oxford. 
[18] Wakeyama, H., Takeshige, K., Takayanagi, R. 
and Minakami, S. (1982) Biochem. J. 205, 
593-601. 
[19] Kakinuma, K. and Minakami, S. (1978) Biochim. 
Biophys. Acta 538, 50-59. 
[20] Babior, B.M., Curnutte, ,I.T. and McMurrich, B.J. 
(1976) J. Clin. Invest. 58, 989-996. 
[21] Cross, A.R., Higson, F.K. and Jones, O.T.G. 
(1982) Biochem. J. 204, 479-485. 
[221 Bos, A., Wever, R. and Roos, D. (1978) Biochim. 
Biophys. Acta 525, 37-44. 
[23] Odajima, T. (1980) ,i. Biochem. 87, 379-391. 
[24] Lowry, O.H., Rosebrough, N.J., Farr, A.L. and 
Randall, R.J. (1951) ,i. Biol. Chem. 193,265-275. 
[25] Laemmli, U.K. (1970) Nature 227, 680-685. 
[26] Yamaguchi, T., Sato, K., Shimada, K. and 
Kakinuma, K. (1982) J. Biochem. 91, 31-40. 
[27] Hata, A., Kirino, Y., Matsuura, K., Itoh, S., 
Hiyama, T., Konishi, K., Kita, K. and Anraku, Y. 
(1985) Biochim. Biophys. Acta 810, 62-72. 
[28] Malmstr6m, B.G. (1979) Biochim. Biophys. Acta 
549, 281-303. 
[29] Poole, R.K. (1983) Biochim. Biophys. Acta 726, 
205-243. 
[30] Papini, E., Grzeskowiak, M., Bellavite, P. and 
Rossi, F. (1985) FEBS Lett. 190, 204-208. 
[31] Iizuka, T., Kanegasaki, S., Makino, R., Tanaka, 
T. and lshimura, Y. (1985) ,i. Biol. Chem. 260, 
12049-12053. 
284 
